Pharmacogenetics in Africa, an Opportunity for Appropriate Drug Dosage Regimens: on the Road to Personalized Healthcare.

about

Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01.

P2860

Q41747771-8CA78228-2FF1-466C-8FB9-2840A94D661D

P2860

Pharmacogenetics in Africa, an Opportunity for Appropriate Drug Dosage Regimens: on the Road to Personalized Healthcare.

Item

http://www.wikidata.org/entity/Q45920621

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Pharmacogenetics in Africa, an ...... ad to Personalized Healthcare.

@en

Pharmacogenetics in Africa, an ...... ad to Personalized Healthcare.

@nl

type

Item

label

Pharmacogenetics in Africa, an ...... ad to Personalized Healthcare.

@en

Pharmacogenetics in Africa, an ...... ad to Personalized Healthcare.

@nl

prefLabel

Pharmacogenetics in Africa, an ...... ad to Personalized Healthcare.

@en

Pharmacogenetics in Africa, an ...... ad to Personalized Healthcare.

@nl

P1476

Pharmacogenetics in Africa, an ...... ad to Personalized Healthcare.

@en

P2093

C Masimirembwa

http://www.w3.org/2001/XMLSchema#string

J A Hasler

http://www.w3.org/2001/XMLSchema#string

P2860

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping

The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications.

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity.

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy

Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms.

A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity.

High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe.

Establishment of a biobank and pharmacogenetics database of African populations.

P304

e45-

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PSP.2013.17

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273497196

http://www.w3.org/2001/XMLSchema#string

P932

3674327

http://www.w3.org/2001/XMLSchema#string

Pharmacogenetics in Africa, an Opportunity for Appropriate Drug Dosage Regimens: on the Road to Personalized Healthcare.

about

P2860

P2860

Pharmacogenetics in Africa, an Opportunity for Appropriate Drug Dosage Regimens: on the Road to Personalized Healthcare.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P932